Method and system for detecting related substances of buspirone hydrochloride starting material

Through the combination of reverse phase high-performance liquid chromatography and ultraviolet detector, the problem of impurity detection in the starting materials of buspirone hydrochloride is solved, and the effective detection and impurity separation of the starting materials of buspirone hydrochloride is achieved, ensuring that Strict control of drug quality.

CN119023833APending Publication Date: 2024-11-26WUHAN HAITE BIOLOGICAL INNOVATIVE PHARM RES CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411074764.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

There is a lack of effective detection methods in the prior art to control impurities in the starting materials of buspirone hydrochloride, affecting the quality of the drug and adverse reactions in clinical use.

Method used

Inverse phase high performance liquid chromatography combined with UV detector, phosphate buffer and acetonitrile as mobile phases were used to detect the starting material of buspirone hydrochloride in a liquid chromatograph through a gradient elution program, and impurities were isolated and identified. Establish detection methods and systems.

Benefits of technology

Effective separation and detection of impurities in the starting material of buspirone hydrochloride is achieved. The control analysis time is within 30 minutes, and the separation between the main components and impurities is not less than 1.5, ensuring strict control of drug quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119023833A_ABST
    Figure CN119023833A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field, and particularly provides a method and a system for detecting related substances of a buspirone hydrochloride starting material. The method comprises the following steps: dissolving by using a phosphate buffer solution as a diluent, quantitatively diluting to prepare a mixed solution containing 0.5-2.0 mg / ml of a buspirone hydrochloride starting material per 1ml of the diluent, taking 5.0-20.0 microliters of a sample solution, injecting the sample solution into a liquid chromatograph, recording a chromatogram, and detecting the purity of an intermediate, the content of impurities and the size of residual solvent; according to the method, the related substances of the buspirone hydrochloride starting material are measured by adopting a high performance liquid chromatography and using a phosphate buffer solution as a diluent, the separation degree of the related substances in the buspirone hydrochloride starting material in the method meets the requirement, a test sample is convenient to prepare, and the stability of a test sample solution is relatively good.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to the field of pharmaceutical detection technology, and in particular to a detection method and system for substances related to buspirone hydrochloride starting materials. Background Art

[0002] Buspirone hydrochloride is a non-benzodiazepine antianxiety drug. It is mainly used to treat various anxiety disorders, depressive states, maladaptive behaviors, and as an auxiliary treatment for obsessive-compulsive disorder. As a new type of antianxiety drug, long-term use of buspirone hydrochloride does not produce sedation, withdrawal reactions, or drug dependence. Sudden discontinuation of the drug will not have side effects and will not affect life. In the research and development of new and generic drugs, impurities are the key quality attributes that affect the product. The control of impurities is also one of the difficulties in drug research and development. In addition to being related to the pharmacological activity of the main ingredients, the adverse reactions of drugs in clinical use are also closely related to the impurities present in the drugs.

[0003] Buspirone hydrochloride starting material 01 (hereinafter referred to as buspirone hydrochloride starting material), English name is 2-Chloropyrimidine, chemical name is 2-chloropyrimidine, molecular formula is C4H3ClN2, molecular weight is 114.53, CAS number is 1722-12-9, chemical structure is as follows:

[0004]

[0005] According to the concept of source control and process control, effective detection methods should also be established for the preparation of buspirone hydrochloride starting materials to implement strict control. After searching, no relevant patents or public literature reports on the detection methods of related substances in buspirone hydrochloride starting materials have been found. Summary of the invention

[0006] The present disclosure aims to solve at least one of the technical problems existing in the prior art, and proposes a method and system for detecting related substances of buspirone hydrochloride starting materials.

[0007] In the first aspect, the present disclosure provides a method for detecting substances related to buspirone hydrochloride starting material, wherein the starting material has a chemical name of 2-chloropyrimidine, a molecular formula of C4H3ClN2, and a structural formula of

[0008]

[0009] The following steps are involved:

[0010] S1, dissolving buspirone hydrochloride starting material in phosphate buffer as a diluent, and quantitatively diluting to prepare a mixed solution containing 0.5-2.0 mg / ml of buspirone hydrochloride starting material per 1 ml of diluent;

[0011] S2, taking 5.0-20.0 μl of the sample solution and injecting it into the liquid chromatograph, recording the chromatogram, and completing the detection of related substances of the buspirone hydrochloride starting material.

[0012] Preferably, the detection method adopts reverse phase high performance liquid chromatography and uses an ultraviolet detector for detection.

[0013] Preferably, the detection conditions of the reversed-phase high performance liquid chromatography are as follows:

[0014] Chromatographic column: Octadecylsilane bonded silica gel is used as the chromatographic column filler, and the column temperature is 25-45°C;

[0015] Mobile phase: Phase A is phosphate buffer; Phase B is acetonitrile; flow rate is 0.6-1.0 ml / min;

[0016] Elution program: gradient elution;

[0017] Injector temperature: 4 °C;

[0018] Detection wavelength: 200nm~240nm.

[0019] Preferably, the phosphate buffer is a potassium dihydrogen phosphate solution with a pH of 5.5 to 6.5, and the molar concentration of potassium dihydrogen phosphate is 0.mol / L.

[0020] Preferably, the gradient elution procedure is:

[0021] In 0-2.5min, phase B is 3%;

[0022] Phase B changed from 3% to 15% in 2.5-13 min;

[0023] In 13-18 min, phase B changed from 15% to 65%;

[0024] In 18-22 min, phase B was 65%;

[0025] In 22-22.1 min, phase B changed from 65% to 3%;

[0026] In 22.1-27 min, phase B was 3%.

[0027] Preferably, the injection volume of the liquid injector is 10.0 μl.

[0028] The present invention also provides a detection system for related substances of buspirone hydrochloride starting materials, the detection system can be used to implement the detection method of related substances of buspirone hydrochloride starting materials, the detection system comprises:

[0029] A liquid preparation module, used for dissolving the buspirone hydrochloride starting material with a phosphate buffer as a diluent, and quantitatively diluting the solution to prepare a mixed solution containing 0.5 to 2.0 mg / ml of the buspirone hydrochloride starting material per 1 ml of the diluent;

[0030] The detection module is used to take 5.0 to 20.0 μl of sample solution and inject it into the liquid chromatograph, record the chromatogram, and complete the detection of related substances of the buspirone hydrochloride starting material. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 It is a chromatogram of a blank solution in an embodiment of the present invention;

[0032] Figure 2 It is a chromatogram of the separation solution in the embodiment of the present invention;

[0033] Figure 3 It is a chromatogram of the test solution in the implementation case of the present invention. DETAILED DESCRIPTION

[0034] In order to enable those skilled in the art to better understand the technical solution of the present disclosure, the present disclosure is further described in detail below in conjunction with the accompanying drawings and specific implementation methods.

[0035] In each of the accompanying drawings, the same elements are represented by similar reference numerals. For the sake of clarity, the various parts in the accompanying drawings are not all drawn to scale. In addition, some well-known parts may not be shown in the drawings.

[0036] The embodiment of the present invention provides a method for detecting related substances of buspirone hydrochloride starting material, wherein the starting material has a chemical name of 2-chloropyrimidine, a molecular formula of C4H3ClN2, and a structural formula of

[0037]

[0038] The following steps are involved:

[0039] S1, dissolving buspirone hydrochloride starting material in phosphate buffer as a diluent, and quantitatively diluting to prepare a mixed solution containing 0.5-2.0 mg / ml of buspirone hydrochloride starting material per 1 ml of diluent;

[0040] S2, taking 5.0-20.0 μl of the sample solution and injecting it into the liquid chromatograph, recording the chromatogram, and completing the detection of related substances of the buspirone hydrochloride starting material.

[0041] Four impurities were identified in the synthesis process of buspirone hydrochloride starting materials:

[0042]

[0043] The present invention screens chromatographic conditions and can effectively separate four impurities, establishes a related substance detection method, controls the analysis time within 30 minutes, and the separation degrees between the main component and the related substances, and between the related substances are not less than 1.5, thereby achieving the purpose of the above invention.

[0044] The specific HPLC detection chromatographic conditions are as follows:

[0045] Separation solution: Take appropriate amounts of buspirone hydrochloride material, impurity A, impurity B, impurity C and impurity D, weigh accurately, add 0.mol / L phosphate buffer (pH 6.0±0.05) to dissolve and quantitatively dilute to a mixed solution containing about 1.0 mg of starting material 02, about 5.0 μg of impurity A, about 5.0 μg of impurity B, about 5.0 μg of impurity C and about 5.0 μg of impurity D per 1 ml.

[0046] Test solution: Take an appropriate amount of the product, weigh accurately, add 0.mol / L phosphate buffer (pH 6.0±0.05) to dissolve and quantitatively dilute to make a solution containing about 1.0 mg per 1 ml.

[0047] Reference solution: Accurately measure 0.1 ml of the test solution and place it in a 100 ml volumetric flask. Add 0.mol / L phosphate buffer (pH 6.0 ± 0.05) to dilute to the scale and shake well.

[0048] Blank solution chromatogram Figure 1 , the separation solution chromatogram is shown in Figure 2 , the chromatogram of the test solution is shown in Figure 3 .

[0049] Chromatographic conditions:

[0050] Octadecylsilane bonded silica gel is used as filler (Agilent poroshell 120EC-C18 (100×4.6 mm, 2.7 μm) is suitable or a chromatographic column with equivalent performance).

[0051] Welch Ghost-Buster Column II (50 × 4 mm) was used as the trapping column;

[0052] Phosphate buffer (weigh 1.36 g potassium dihydrogen phosphate, dissolve in 1000 ml water, and adjust the pH to 6.00±0.05 with 1 mol / L phosphoric acid) was used as mobile phase A.

[0053] Acetonitrile was used as mobile phase B.

[0054] Perform gradient elution according to the following table:

[0055] The detection wavelength is 210 nm.

[0056] The column temperature was 45°C.

[0057] Time (mmin) Phase A (%) Phase B (%) 0 97 3 2.5 97 3 13 85 15 18 35 65 22 35 65 22.1 97 3 27 97 3

[0058] The flow rate was 1.0 ml per minute.

[0059] The injector temperature was 4 °C.

[0060] The injection volume was 10 μl.

[0061] calculate:

[0062] Single impurity: Calculate the content of each single impurity by the self-control method with correction factor added; Total impurity: The sum of individual impurities, impurities not less than LOD are included in the calculation of total impurities.

[0063] The correction factors are shown in the table below:

[0064] name Correction Factor Impurity A 0.57 Impurity C 0.79 Impurity B 2.25 Impurity D 0.72 Unknown impurities 1.0

[0065] Specific data reference:

[0066] Sensitivity test:

[0067]

[0068]

[0069] Linear investigation:

[0070]

[0071]

[0072]

[0073]

[0074] Accuracy test:

[0075]

[0076]

[0077] Unknown impurities: None.

[0078] Solution stability study:

[0079]

[0080] The embodiment of the present invention also provides a detection system for related substances of buspirone hydrochloride starting materials, and the detection system can be used to implement the detection method of related substances of buspirone hydrochloride starting materials, and the detection system includes:

[0081] A liquid preparation module, used for dissolving the buspirone hydrochloride starting material with a phosphate buffer as a diluent, and quantitatively diluting the solution to prepare a mixed solution containing 0.5 to 2.0 mg / ml of the buspirone hydrochloride starting material per 1 ml of the diluent;

[0082] The detection module is used to take 5.0 to 20.0 μl of sample solution and inject it into the liquid chromatograph, record the chromatogram, and complete the detection of related substances of the buspirone hydrochloride starting material.

[0083] It is to be understood that the above embodiments are merely exemplary embodiments used to illustrate the principles of the present disclosure, but the present disclosure is not limited thereto. For those of ordinary skill in the art, various modifications and improvements can be made without departing from the spirit and substance of the present disclosure, and these modifications and improvements are also considered to be within the scope of protection of the present disclosure.

Claims

1. A method for detecting related substances of buspirone hydrochloride starting material, wherein the starting material has a chemical name of 2-chloropyrimidine, a molecular formula of C4H3ClN2, and a structural formula of It is characterized in that The following steps are involved: S1, dissolving buspirone hydrochloride starting material in phosphate buffer as a diluent, and quantitatively diluting to prepare a mixed solution containing 0.5-2.0 mg / ml of buspirone hydrochloride starting material per 1 ml of diluent; S2, taking 5.0-20.0 μl of the sample solution and injecting it into the liquid chromatograph, recording the chromatogram, and completing the detection of related substances of the buspirone hydrochloride starting material.

2. The method for detecting related substances of buspirone hydrochloride starting material according to claim 1, characterized in that, The detection method adopts reverse phase high performance liquid chromatography and uses an ultraviolet detector for detection.

3. The method for detecting related substances of buspirone hydrochloride starting material according to claim 2, characterized in that, The detection conditions of the reversed-phase high performance liquid chromatography are as follows: Chromatographic column: Octadecylsilane bonded silica gel is used as the chromatographic column filler, and the column temperature is 25-45°C; Mobile phase: Phase A is phosphate buffer; Phase B is acetonitrile; flow rate is 0.6-1.0 ml / min; Elution program: gradient elution; Injector temperature: 4 °C; Detection wavelength: 200nm~240nm.

4. The method for detecting related substances of buspirone hydrochloride starting material according to claim 3, characterized in that, The phosphate buffer is a potassium dihydrogen phosphate solution with a pH of 5.5 to 6.5, and the molar concentration of potassium dihydrogen phosphate is 0.mol / L.

5. The method for detecting related substances of buspirone hydrochloride starting material according to claim 3, characterized in that, The gradient elution procedure is: In 0-2.5min, phase B is 3%; Phase B changed from 3% to 15% in 2.5-13 min; In 13-18 min, phase B changed from 15% to 65%; In 18-22 min, phase B was 65%; In 22-22.1 min, phase B changed from 65% to 3%; In 22.1-27 min, phase B was 3%.

6. The method for detecting related substances of buspirone hydrochloride starting material according to claim 3, characterized in that: The injection volume of the liquid injector is 10.0 μl.

7. A detection system for related substances of buspirone hydrochloride starting material, characterized in that: The detection system can be used to implement the detection method of the buspirone hydrochloride starting material related substances described in any one of claims 1 to 6 above, and the detection system comprises: A liquid preparation module, used for dissolving the buspirone hydrochloride starting material with a phosphate buffer as a diluent, and quantitatively diluting the solution to prepare a mixed solution containing 0.5 to 2.0 mg / ml of the buspirone hydrochloride starting material per 1 ml of the diluent; The detection module is used to take 5.0 to 20.0 μl of sample solution and inject it into the liquid chromatograph, record the chromatogram, and complete the detection of related substances of the buspirone hydrochloride starting material.